Swetha Kanduri
swethakanduri.bsky.social
Swetha Kanduri
@swethakanduri.bsky.social
May 3, 2025 at 6:13 PM
May 3, 2025 at 3:23 PM
Excited doing Urine Microscopy work shop with enthusiastic group at @KIDNEYcon with @jrseltzer and @VelezNephHepato
May 3, 2025 at 2:47 PM
Excited doing Urine Microscopy work shop with enthusiastic group at @KIDNEYcon with @jrseltzer and @VelezNephHepato
May 3, 2025 at 2:45 PM
Roger Rodby highlighting PO4 Reabsorption and TumorInduced osteomalacia causing elevated Po4wasting
May 2, 2025 at 4:20 PM
Phenomenal talk on Electrolyte abnormalities, Mg and PO4 by one of the gurus in the field @RogerRodby @kidneycon.bsky.social
#KidneyCon2025
May 2, 2025 at 4:02 PM
Happy to share our case based onconephrology web series @isnkidneycare.bsky.social

Expand your expertise in complex cancer-related kidney disease cases   - International Society of Nephrology
@sabinekaram.bsky.social

t.co/J8eU9klFnc
https://www.theisn.org/blog/2025/04/28/new-case-based-onconephrology-video-series-expand-your-expertise-in-complex-cancer-related-kidney-disease-cases/
t.co
April 29, 2025 at 1:21 PM
Reposted by Swetha Kanduri
Glucarpidase receipt was also associated with a lower adjusted odds of grade ≥2 transaminitis and grade ≥2 neutropenia. buff.ly/a88VOV9 #hemesky #clincialtrialsandobservations
April 28, 2025 at 3:03 PM
Reposted by Swetha Kanduri
We are getting closer and closer to @kidneycon.bsky.social 2025! Top notch speakers, exciting topics. A couple of outstanding workshops to highlight today: Home Dialysis and Comparative Physiology, yes, for the #NephMadness Animal Region 🦎 lovers and Channel Your Enthusiasm podcast listeners 🎙️
April 15, 2025 at 3:04 PM
Happy to share our recent publication on “Recovery from acute kidney injury treated with dialysis in patients with multiple myeloma treated with proteasome inhibitors” @juancarlosqvelez.bsky.social #NDT #OxfordPublications
#OncoNephrology
academic.oup.com/ndt/advance-...
Recovery from acute kidney injury treated with dialysis in patients with multiple myeloma treated with proteasome inhibitors
To the Editor,
academic.oup.com
April 7, 2025 at 5:42 PM
Reposted by Swetha Kanduri
Etiology of AKI in cirrhosis
#Nephpearls #RPA2025 🎰 #NephSky

👉🏼 pubmed.ncbi.nlm.nih.gov/38070000/
April 6, 2025 at 6:02 PM
Reposted by Swetha Kanduri
For those interested in glomerular stuff, you gotta see our line-up for the Glom Dis session at KidneyCon! And they will attack the topics that make all of us scratch our heads. Register ASAP, May 1-3 #KidneyCon 2025 @isgd.bsky.social @glomcon.org @kidneycon.bsky.social

kidneycon.org
April 1, 2025 at 6:29 PM
Great opportunities to deepen the knowledge on urine microscopy techniques and it’s clinical utility

🌟Come join us for a hands on work shop with experts in the field at @kidneycon.bsky.social, May 1-3 2025 @juancarlosqvelez.bsky.social @jrseltzer.bsky.social

kidneycon.org/registration
April 1, 2025 at 6:44 PM
Reposted by Swetha Kanduri
Interested in learning more about the art of microscopic examination of the urinary sediment and its clinical applications? @jrseltzer.bsky.social @swethakanduri.bsky.social and I will be running a Hands-On Workshop at KidneyCon this year. Come join us! @kidneycon.bsky.social May 1-3. Register ASAP
April 1, 2025 at 6:26 PM
Reposted by Swetha Kanduri
Cystinuria and nephrolithiasis. #UrinarySediment #UrineMicroscopy #Crystalluria
March 23, 2025 at 5:03 PM
Reposted by Swetha Kanduri
Airport bound ✈️. Looking forward to this 💪💪 #hepatorenal #renalfellows
March 23, 2025 at 4:40 PM
Reposted by Swetha Kanduri
March 24, 2025 at 5:28 AM
Reposted by Swetha Kanduri
Fantastic. Thanks for sharing. Here for more on the mechanisms of hydrANCAzine

bsky.app/profile/juan...

@hswapnil.medsky.social
@amyaimei.bsky.social
1/n HydrANCAzine (hydralazine-induced ANCA-associated vasculitis has turn into an important cause of crescentic glomerulonephritis. Wonder how does hydralazine do it? Here is a tweetorial (BlueSkytorial?). I’ll start with an animation that summarizes and simplifies a proposed mechanism.
March 4, 2025 at 11:06 PM
Reposted by Swetha Kanduri
With the massive use of GLP-1As worldwide, we’ll soon know if this was an extremely rare isolated phenomenon or something that others may also encounter
March 3, 2025 at 5:07 PM
Happy to share our publication on a case of Minimal Change Podocytopathy with coexisting Thin Basement Membrane following exposure to Semaglutide @juancarlosqvelez.bsky.social

karger.com/gdz/article/...
Minimal Change Podocytopathy with Coexistent Thin Glomerular Basement Membrane following Exposure to Semaglutide
Abstract. Introduction: Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are FDA-approved for weight loss and are increasingly prescribed for patients with obesity and type 2 diabetes mellitus. Mu...
karger.com
March 3, 2025 at 3:54 PM
Wrapping up a great session “Looking into the Crystal Ball-Where will we be 5 years from now with amazing speaker panel.
Had fun Co-Charing the session along with Dr Rajkumar Sharma
#ISNWCN
February 8, 2025 at 11:01 AM
Reposted by Swetha Kanduri
A reminder that the #ISNWCN Social Media Team will be covering the World Congress of Nephrology in New Delhi starting in less than 2 days time on the 6th February 2025 and bring to you the latest happenings at the conference.
@theisn.org @isn-india.bsky.social @myadla.bsky.social
February 4, 2025 at 4:05 PM
Reposted by Swetha Kanduri
Registration is open for KIDNEYcon 2025
May 1-3
Little Rock, AR
kidneycon.org/registration
Registration — KIDNEYcon
Registration
kidneycon.org
January 28, 2025 at 8:52 PM
Reposted by Swetha Kanduri
Yes! Amazing work @jmteakell.bsky.social Now how do we scale this throughout the US? #NephSky
January 26, 2025 at 6:24 PM